Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.33 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18286558 | 0.87 | LMNA (0.43) | SLC7A5SLC1A3SLC1A2SLC1A1PTGS1 | |
| SCHEMBL9617308 | 0.87 | LMNA (0.43) | SLC7A5SLC1A3SLC1A2SLC1A1PTGS1 | |
| SCHEMBL468084 | 0.83 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL29957453 | 0.83 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL25933046 | 0.83 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL600021 | 0.83 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL1007447 | 0.83 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL4632980 | 0.79 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL4633860 | 0.79 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| Hydrochloric Acid SCHEMBL11095114 | 0.79 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112585157-A | Peptide ligands for binding integrin α v β 3 | 拜斯科技术开发有限公司 | 2021-03-30 | — | — | CN | claimed |
| US-20180298055-A1 | INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS | BHATNAGAR RAJENDRA SAHAI (US) | 2018-10-18 | — | — | US | claimed |
| US-10030048-B2 | Inhibitors of NF κ-B activity for treatment of diseases and disorders | BHATNAGAR RAJENDRA SAHAI (US) | 2018-07-24 | — | — | US | claimed |
| US-7015309-B1 | Pyrrhocoricin-derived peptides, and methods of use thereof | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2006-03-21 | — | — | US | claimed |
| EP-1194548-A4 | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES, AND METHODS OF USE THEREOF | WISTAR INST (US) | 2003-06-18 | — | — | EP | claimed |
| EP-1194548-A1 | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES, AND METHODS OF USE THEREOF | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2002-04-10 | — | — | EP | claimed |
| WO-2000078956-A1 | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES, AND METHODS OF USE THEREOF | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2000-12-28 | — | — | WO | claimed |
| US-20240180997-A1 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | BHATNAGAR RAJENDRA SAHAI (US) | 2024-06-06 | — | — | US | disclosed |
| US-20240083941-A1 | INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS | BHATNAGAR RAJENDRA SAHAI (US) | 2024-03-14 | — | — | US | disclosed |
| US-11773135-B2 | Inhibitors of NF kappa-B activity for treatment of diseases and disorders | BHATNAGAR RAJENDRA SAHAI (US) | 2023-10-03 | — | — | US | disclosed |
| EP-4203988-A2 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | Bhatnagar, Rajendra, Sahai (US) | 2023-07-05 | — | — | EP | disclosed |
| EP-3197474-B1 | INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS | BHATNAGAR RAJENDRA SAHAI (US) | 2023-06-07 | — | — | EP | disclosed |
| CN-114432423-A | NF for treating diseases and disorderskInhibitors of B activity | 拉金德拉·萨哈伊·巴特纳格尔 | 2022-05-06 | — | — | CN | disclosed |
| US-20050181987-A1 | Compositions and methods for treatment of cancer | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2005-08-18 | — | — | US | disclosed |
| EP-1194548-A4 | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES, AND METHODS OF USE THEREOF | WISTAR INST (US) | 2003-06-18 | — | — | EP | disclosed |
| WO-2000027420-A9 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | — | 2002-04-25 | — | — | WO | disclosed |
| EP-1194548-A1 | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES, AND METHODS OF USE THEREOF | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2002-04-10 | — | — | EP | disclosed |
| WO-2000078956-A1 | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES, AND METHODS OF USE THEREOF | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2000-12-28 | — | — | WO | disclosed |
| WO-2000027420-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-1992002543-A1 | NOVEL IMMUNOSUPPRESSANT PEPTIDES | CYTEL CORPORATION (US) | 1992-02-20 | — | — | WO | disclosed |